Home > Insider Trading > Filing (0001181431-13-027934)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1454983	S Richard Levy	Experimental Station Route 141 And Henry Clay Rd Wilmington DE 19880	Evp, Chief Drug Dev&Medical Of	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-05-13	55,699	$7.09	55,699	No	4	M	Direct
Common Stock	Acquisiton	2013-05-13	4,301	$7.09	60,000	No	4	M	Direct
Common Stock	Disposition	2013-05-13	55,699	$22.30	4,301	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-05-13	55,699	$0.00	55,699	$7.09
Common Stock	Incentive Stock Option (right to buy)	Disposition	2013-05-13	4,301	$0.00	4,301	$7.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-02-11	No	4	M	Direct
0		2014-02-11	No	4	M	Direct

Footnotes

Represents weighted average sale price. Actual sales prices ranged from $23.24 to $23.41.
Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Beginning February 12, 2007 options become exercisable in 25 installments, with the first installment of 33.33% vesting after one year and the remaining vesting monthly over two years.